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http://www.virologyj.com/content/10/1/258RESEARCH Open AccessJapanese encephalitis virus infects porcine kidney
epithelial PK15 cells via clathrin- and cholesterol-
dependent endocytosis
Songbai Yang, Minhui He, Xiangdong Liu, Xinyun Li, Bin Fan* and Shuhong Zhao*Abstract
Background: Japanese encephalitis virus (JEV) is a mosquito-borne flavivirus that causes acute viral encephalitis in
humans. Pigs are important amplifiers of JEV. The entry mechanism of JEV into porcine cells remains largely
unknown. In this study, we present a study of the internalization mechanism of JEV in porcine kidney epithelial
PK15 cells.
Results: We demonstrated that the disruption of the lipid raft by cholesterol depletion with methyl-β-cyclodextrin
(MβCD) reduced JEV infection. We also found that the knockdown of clathrin by small interfering RNA (siRNA)
significantly reduced JEV-infected cells and JEV E-glycoprotein levels, suggesting that JEV utilizes clathrin-dependent
endocytosis. In contrast, the knockdown of caveolin-1, a principal component of caveolae, had only a small
(although statistically significant) effect on JEV infection, however, JEV entry was not affected by genistein. These
results suggested that JEV entry was independent of caveolae.
Conclusions: Taken together, our results demonstrate that JEV enters porcine kidney epithelial PK15 cells through
cholesterol- and clathrin-mediated endocytosis.
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Japanese encephalitis virus (JEV) is a mosquito-borne
flavivirus that belongs to the family Flaviviridae. JEV is
one of the most important endemic encephalitides and
can cause acute viral encephalitis, of which there are ap-
proximately 50,000 cases in humans annually [1]. JEV
can infect a wide range of cells of different origins. Pigs
act as amplifying hosts of JEV; therefore, the domestic
pig was considered to be a risk factor in the transmission
of the disease to humans [2,3]. JEV is also an important
pathogen in swine and causes considerable economic
losses in pork production. The primary symptoms of
pigs infected with JEV are fetal abortion and stillbirth in
infected sows and aspermia in boars [4,5]. JEV has a
single-stranded positive-sense RNA genome of approxi-
mately 11 kb. The viral RNA encodes a single large
polyprotein that is cleaved into three structural proteins,* Correspondence: fanbin@mail.hzau.edu.cn; shzhao@mail.hzau.edu.cn
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reproduction in any medium, provided the orcapsid (C), precursor membrane (prM) and envelope
(E); and seven non-structural (NS) proteins, NS1, NS2a,
NS2b, NS3, NS4a, NS4b and NS5. The JEV E protein is
the major structural protein exposed on the surface of
the virus particle and mediates binding and fusion dur-
ing virus entry [6,7].
Viruses enter cells through binding cellular recep-
tors. The interactions between the viruses and
receptors are highly specific, determining which cell
types and species can be infected. Additionally, the
entrance of viruses into the host cells involves se-
veral endocytic pathways, including clathrin-mediated,
caveolae-mediated, cholesterol-dependent endocytosis,
macropinocytosis/phagocytosis and other mechanisms
[8,9]. Clathrin-mediated endocytosis (CME) is the best
characterized of the endocytic mechanisms, and most
viruses utilize this type of endocytosis to enter cells.
Recent studies have shown that JEV infects neuronal
cells through a clathrin-independent, dynamin- and
caveolae-mediated endocytosis pathway [10,11]. Previ-
ous studies have found that JEV enters Vero and Huh7d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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addition, JEV internalisation into neural stem cells occurs
by clathrin-mediated, caveolae independent endocytosis
[14]. Persistent JEV infection has been demonstrated in
porcine kidney cells [15] and numerous studies on JEV
have been conducted in porcine kidney cells [16-20]. More-
over, vimentin has been identified as mediating the entry of
JEV into porcine kidney cells [21]. However, the precise
entry mechanism for JEV internalization into porcine cells
remains unclear.
In this study, we define the role of cholesterol in JEV
infection through cholesterol depletion, which significantly
decreased JEV infection. In addition, we used RNA interfer-
ence (RNAi) to examine the roles of clathrin and caveolin-1
in the JEV entry process; the results indicated that knock-
down of clathrin reduced JEV infection, however, knock-
down of caveolin-1 showed only a small effect on JEV
infection and JEV entry was not affected by genistein. These
results indicate that JEV endocytosis in PK15 cells is
dependent on cholesterol and clathrin but not on caveolae.Figure 1 Depletion of cholesterol by MβCD inhibits JEV infection. (A)
JEV in the presence of inhibitor; 36 hours post-infection (hpi), the cells wer
IgG secondary antibodies. The nuclei were stained with DAPI. Scale bars, 50
then infected with JEV; 36 hpi, the cells were lysed and processed for west
loading control. +, control cells untreated with MβCD; -, control without JE
mM MβCD for 1 h at 37°C and then incubated with 10 μg/ml AF 555-label
DAPI. Bar, 10 μm. (D) PK15 cells were plated on 96-well plates and then eit
at 37°C. After treatment, cell viability was determined with a CCK-8 kit. The
independent experiments.Results
JEV infection is inhibited by the depletion of cholesterol
Many viruses commonly use lipid rafts to enter host
cells. Cholesterol is a prominent component of lipid
rafts. Membrane cholesterol can be disrupted by
pharmacological agents, in which MβCD extracts mem-
brane cholesterol selectively [22], resulting in lipid raft
disruption. Previous studies showed that the depletion of
cholesterol could inhibit JEV infection during early
stages [11,14,23]. To determine whether the removal of
cholesterol affected the infection of PK15 cells with JEV,
cells were treated with 10 nM MβCD and then incu-
bated with JEV. After treatment, the internalization of
JEV into cells was determined by immunofluorescence
staining. As shown in Figure 1A, the treatment of the
cells with 10 mM MβCD significantly decreased JEV in-
fection compared with the untreated control (0 mM). In
addition, after the cells were treated with 1, 5, or 10 mM
MβCD and then infected with JEV, western blot analysis
showed that the expression of JEV E protein was alsoPK15 cells were treated with 10 mM MβCD for 1 h and infected with
e fixed and stained with anti-JEV E primary and Alexa488 anti-mouse
μm. (B) The cells were treated with MβCD as described above and
ern blot analysis of JEV E protein. β-actin was used as an internal
V infection. (C) PK15 cells were untreated (control) or treated with 10
led Cholera toxin B (CTxB) for 30 min at 37°C. Nuclei were stained with
her left untreated (as a control) or treated with MβCD (10 mM) for 6 h
results are presented as the mean ± SD of three
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http://www.virologyj.com/content/10/1/258inhibited. As shown in Figure 1B, JEV E protein expression
was significantly inhibited by MβCD at the concentrations
of 5 mM or higher. These concentrations of MβCD were
previously reported to significantly deplete membrane chol-
esterol [11,24]. Cholera toxin B (CTxB) is internalized in a
lipid-raft-dependent manner after binding to its receptor
GM1 ganglioside [25]. To confirm that MβCD treatment
resulted in inhibition of CTxB, we analyzed the effect of the
drug on CTxB uptake. As shown in Figure 1C, untreated
cells allowed CTxB uptake and showed a clear dotted peri-
nuclear cytoplasmic fluorescence, whereas CTxB internal-
ization was blocked when cells were treated with MβCD,
confirming that lipid-raft-dependent endocytosis was
inhibited. Cell proliferation and toxicological tests were de-
termined by the CCK-8 kit. The results showed that the
cells treated with 10 mM MβCD had no significant differ-
ence of absorbance from the control (Figure 1D). These ob-
servations suggested that JEV infection is dependent on the
cellular membrane cholesterol content.
Entry of JEV into PK15 cells is caveolae independent
Recently, it has been shown that JEV enters rat neuro-
blastoma cells through a caveolae-mediated endocytosis
pathway [11]. caveolin-1 is the principal component ofFigure 2 Caveolin-1 is not required for JEV entry. PK15 cells were trans
and infected with JEV at 48 h post-transfection, 36 hpi. (A) The percentage
cytometry and normalized to the value for the siCtrl. The results are presen
protein was analyzed by western blot analysis. β-actin was used as an inter
densities of protein bands were measured by ImageJ software, and the res
Caveolin-1 knockdown cells were analyzed at 48 h post-transfection by the
as a bar graph under the immunoblot. *, p<0.05.caveolae. The knockdown of caveolin-1 by RNA interfer-
ence (RNAi) decreased the number of membrane
caveolae [26]. To test whether the entry of JEV into
PK15 cells occurs via caveolae-mediated endocytosis,
PK15 cells were transfected with siRNA targeting
caveolin-1 or control siRNA and then infected with JEV.
A small (although statistically significant) effect on JEV
infection was observed between the caveolin-1 knock-
down cells and cells expressing control siRNA
(Figure 2A). Western blot results showed that the cells
transfected with siCAV1 did not have a marked inhib-
ition in JEV E protein expression (Figure 2B). The si-
lencing efficiency of siCAV1 were analyzed at 48 h
post-transfection by western blot (Figure 2C). These
results suggested a possible role for caveolae in JEV in-
fection. However, genistein, a tyrosine kinase inhibitor
known to disrupt caveola related endocytosis [27], had
no effect on JEV infection at concentrations of 50, 100
and 200 μM (Figure 3A and B).
Cell viability tests were determined by the CCK-8 kit,
minimal cellular cytotoxicity was observed in cells
treated by 200 μM genistein compared with control
(Figure 3C). These concentrations of genistein were pre-
viously reported to significantly inhibit JEV infection infected with siRNA targeting caveolin-1 or non-targeting siRNA (siCtrl)
of internalized viruses of transfected cells was determined by flow
ted as the mean ± SD of three independent experiments. (B) JEV E
nal loading control. -, control without JEV infection. The mean
ults for each gel are shown as a bar graph under the immunoblot. (C)
immunoblotting. The mean densities of the protein bands are shown
Figure 3 Effects of genistein on JEV infection. (A) PK15 cells were treated with 200 μM genistein for 1 h and infected with JEV in the
presence of inhibitor; 36 hours post-infection (hpi), the cells were fixed and stained with anti-JEV E primary and Alexa488 anti-mouse IgG
secondary antibodies. The percentage of internalized viruses of drug-treated cells was determined by flow cytometry and normalized to the value
for the control. NS, not significant. (B) The cells were treated with increasing concentrations of genistein as indicated, then infected with JEV; 36
hpi, the cells were lysed and processed for western blot analysis of JEV E protein. β-actin was used as an internal loading control. +, control cells
untreated with genistein; -, control without JEV infection. The mean densities of the protein bands are shown as a bar graph under the
immunoblot. (C) PK15 cells were untreated (control) or treated with genistein (200 μM) for 6 h at 37°C. Cell viability was determined by CCK-8 kit.
The results are presented as the mean ± SD.
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that, although caveolae-dependent processes may play
some role in JEV infection, caveolae-mediated endocyto-
sis is not the major route by which JEV enters the cell.JEV infects PK15 cells by clathrin-mediated endocytosis
Early studies found that JEV entry into cells occurs by
clathrin-mediated endocytosis and could be inhibited by
chlorpromazine [13,14]. Thus, we examined whether
clathrin-mediated endocytosis plays any role in JEV in-
ternalization. To specifically inhibit clathrin-mediated
endocytosis, siRNAs were used to knockdown the ex-
pression of clathrin heavy chain (CHC). PK15 cells were
transfected with two independent specific siRNAs
against CHC or a control siRNA and then infected with
JEV. The CHC knockdown cells showed a significant re-
duction in JEV infection compared with cells transfected
with control siRNA (Figure 4A). Western blot analysis
showed that the expression of JEV E protein was also
decreased in cells transfected with siCHC compared
with control cells (Figure 4B). The silencing efficiency
of siCHC-1 and siCHC-2 were analyzed at 48 h
post-transfection by western blot (Figure 4C). Theseexperiments suggest that JEV internalization in PK15
cells can occur via a clathrin-dependent mechanism.
Discussion
Lipid rafts are important for a number of cellular pro-
cesses and play vital roles in virus entry [28]. Cholesterol
is a prominent component of lipid rafts. Lipid rafts could
be disrupted by depletion of cholesterol using chemical
drugs, such as MβCD, nystatin and filipin [29-31], and
some evidence suggests that cholesterol is involved in
virus entry [24,32-34]. The inhibition of viral infection
could be rescued by the addition of exogenous choles-
terol. However, excess amounts of cholesterol block
flaviviral infection [35]. Previous studies found that JEV
could enter various cell types through a cholesterol-
dependent pathway [11,13,14,23]. In the present work,
PK15 cells were used to investigate the role of mem-
brane cholesterol in JEV entry. Similar results showed
that membrane cholesterol was an absolute requirement
for JEV infection. Cellular entry is initiated when
flaviviral gpE binds to cell surface receptors [36], and
JEV internalisation occurs in a lipid-raft dependent man-
ner [14]. Therefore, the cellular receptors for JEV may
located within the lipid raft domains.
Figure 4 JEV entry depends on clathrin. PK15 cells were transfected with siRNA targeting clathrin heavy-chain (siCHC) or non-targeting siRNA
(siCtrl) and infected with JEV at 48 h post-transfection. 36 hpi. (A) The percentage of internalized viruses of transfected cells was determined by
flow cytometry and normalized to the value for the siCtrl. The results are presented as the mean ± SD. (B) JEV E protein was analyzed by western
blot analysis. β-actin was used as an internal loading control. -, control without JEV infection. The mean densities of the protein bands are shown
as a bar graph under the immunoblot. (C) Clathrin knockdown cells were analyzed at 48 h post-transfection by the immunoblotting for clathrin.
The mean densities of the protein bands are shown as a bar graph under the immunoblot. **, p<0.01.
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pathways. Recent studies have found that JEV enters rat
neuroblastoma cells via caveolae-mediated endocytosis
[11]. Membrane cholesterol is required for caveolae for-
mation, and caveolae-mediated endocytosis could be
blocked by the depletion of cholesterol using MβCD
[37]. The present study shows that JEV entry is inhibited
after cells were treated with MβCD; thus, we speculated
that caveolae was involved in JEV internalization.
Therefore, drug treatment and small interfering RNA
technology were used to validate whether JEV entry into
PK15 cells was caveolae-dependent. Although the flow
cytometry results showed that the cells transfected with
caveolin-1 siRNA inhibited JEV infection by 15% (statis-
tically significant), suggesting that caveolae-mediated
pathway may play some role in the JEV entry into PK15
cells, JEV infection was not affected by genistein. We
conclude that JEV entry into PK15 cells was caveolae-
independent. In addition, the receptor for JEV on PK15
cells is still uncharacterized. It is possible that a very
small part of receptors was localized in caveolae, thus,
the knockdown of caveolin-1 had a small effect on JEV
infection.
Furthermore, MβCD, which destroys lipid raft struc-
ture by depleting cholesterol, also inhibits clathrin-
coated pit budding [38]. Therefore, we next examinedthe possibility of a clathrin-mediated pathway as an
initial step in JEV entry into PK15 cells. Classic clathrin-
mediated endocytosis is commonly used in virus
internalization, and JEV entry occurs via a classic
clathrin-mediated pathway in neural stem cells and Vero
cells [13,14]. In this study, JEV was also found to enter
PK15 cells through the clathrin-dependent endocytic
pathway. Based on published data and the results
reported here, we assume that JEV is likely to infect dif-
ferent cell types by distinct pathways. The cellular recep-
tors of JEV may be different in different cell types.
However, a correlation between the cell receptors used
and their entry pathway was unknown. Several potential
cellular receptors of JEV were identified [12,39,40], but
the genuine receptors of various cell types need to be
identified to better understand the JEV pathogenic
mechanism and to search for new therapeutic targets.
Conclusion
In the present study, we examined JEV infection using a
chemical inhibitor and siRNA to disrupt different
endocytic pathways in PK15 cells. Our results demon-
strated that JEV entry was mediated by cholesterol- and
clathrin-dependent, though not caveolin-1 dependent,
pathways in PK15 cells. The mechanism of JEV entry in
porcine cells was identified, and this research represents
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PK15 and baby hamster kidney (BHK-21) cell lines
(obtained from the American Type Culture Collection,
Manassas, VA) were cultured in Dulbecco’s Modified
Eagle Medium (DMEM, Thermo Scientific HyClone,
Beijing, China) supplemented with 10% fetal bovine
serum and maintained in a humidified incubator at 37°C
and 5% CO2. The JEV attenuated strain SA14-14-2
(GenBank accession: AF315119.1) was used in this study.
Virus was propagated in BHK-21 cells. To generate virus
stocks, BHK-21 cells were grown in monolayers of 75-
cm2 flasks, and the cells were infected with JEV until
90% confluence was reached. The cells were harvested
when the cytopathic effect was extensive (48 h). Virions
were collected through three freeze-thaw cycles and
centrifugation. Virus titers were determined by the 50%
tissue culture infectious dose (TCID50) [41], and the
virus suspensions at a multiplicity of infection (MOI) of
1 were utilized for all infection experiments.
Antibodies and reagents
Mouse anti-JEV E antibody was used for immunofluor-
escence assays and western blot analysis. Polyclonal
rabbit anti β-actin, caveolin-1 and clathrin heavy
chain antibodies were purchased from Cell Signaling
Technology, Inc. (3 Trash Lane, Danvers, MA 01923,
US). The Cell Counting Kit 8 (CCK-8), DAPI and genis-
tein were purchased from Beyotime Biotechnology, Inc.
(Jiangsu, China). Alexa Fluor 488-labeled goat anti-
mouse IgG and Alexa Fluor 555-conjugated Cholera
toxin B (CTxB) were purchased from Molecular Probes
(Eugene, OR). HRP-conjugated goat-anti-rabbit and
goat-anti-mouse secondary antibodies were purchased
from Proteintech Group, Inc (Wuhan, China). Methyl-
β-cyclodextrin (MβCD) was purchased from Sigma-
Aldrich (St. Louis, MO) and dissolved in water.
Drug treatments and virus infection
PK15 cells were plated on 6-well plates and grown to ap-
proximately 80% confluence at 37°C in a CO2 incubator.
The cells were washed three times with phosphate-
buffered saline (PBS) and then pre-treated with MβCD
or genistein for 1 h at 37°C at various concentrations.
After treatment, the cells were infected with JEV for 1 h
at 37°C in the presence of the chemical. The cells were
washed to remove excess virus and drug, then further
incubated in cell culture medium containing 2% FBS at
37°C with 5% CO2. Western blot and immunofluores-
cence staining analysis for JEV E protein expression were
performed 36 h post-infection.RNA interference experiments
For small interfering RNA (siRNA) analysis, siRNA oli-
gonucleotides with specificity for porcine CAV1 and
clathrin heavy chain (CHC) and non-targeting siRNA
(siCtrl) were synthesized from GenePharma (Shanghai,
China). The target sequence of siCAV1 was as follow:
siCAV1-1 5’- CACACAGUUUCGAUGGCAUCUTT-3’.
Sequences of siCHC-1 (equal mixture of the two RNA
duplex oligonucleotides) were as follows: 5’-AAGC
UGGGAAAACUCUUCAGA-3’, 5’-UAAUCCAAUUCG
AAGACCAAU-3’ [42], siCHC-2: 5’-GGCCCAGGUG
GUAAUUAUUUU-3’. PK15 cells were transfected with
50 nM siRNA using Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s instructions. Subsequent
experiments were performed 48 h post-transfection.
Knockdown efficiencies were quantified by western blot
analysis.Western blot analysis
Cells were washed with PBS three times and lysed in a
modified radioimmunoprecipitation assay (RIPA) lysis
buffer (50 mM Tris (pH 7.4), 150 mM NaCl, 1% Triton
X-100, 1% sodium deoxycholate, 0.1% SDS, 1 mM
phenylmethylsulfonyl fluoride [PMSF]). Protein concen-
trations were determined with a BCA Protein Assay kit
(Solarbio, China). An equal amount of protein lysate was
separated by 12% SDS-polyacrylamide gels and trans-
ferred to PVDF membranes (Millipore, Bedford, MA).
The membranes were blocked with 5% nonfat milk in
tris-buffered saline containing 0.1% tween-20 (TBST)
and then incubated with primary antibodies overnight at
4°C. The membranes were washed three times with
TBST (each wash was 10 min), and HRP-conjugated
goat anti-rabbit or goat-anti-mouse secondary antibody
(1:3000 dilutions in blocking buffer) was added. Bound
antibodies were visualized by SuperSignal West Pico
chemiluminescent substrate (Pierce, Rockford, IL). The
mean densities of protein bands were measured by
ImageJ software (National Institutes of Health, Bethesda,
Maryland).Immunofluorescence assays
The cells were fixed with 4% paraformaldehyde for 20
min at room temperature (RT) and permeabilized with
0.2% Triton X-100 for 15 min. The cells were then incu-
bated with a blocking buffer (PBS containing 5% bovine
serum albumin [BSA]) at 37°C for 30 min. After three
washes with PBS, the cells were stained with anti-JEV E
mouse antibody at room temperature for 1 h. After be-
ing washed with PBS, the cells were incubated with
Alexa Fluor 488 conjugated goat anti-mouse antibody
(1:200 dilutions in blocking buffer) IgG. The nuclei were
stained with DAPI.
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PK15 cells infected with JEV were washed one time with
PBS, detached and transferred to 1.5 ml centrifuge tubes.
The cells were centrifuged at 1000 rpm/min for 10 min
and fixed with 4% paraformaldehyde for 15 min at room
temperature. After being permeabilized with Triton
X-100, the cells were incubated with anti-JEV E mouse
antibody overnight at 4°C. The cells were washed 3
times with PBS then incubated with Alexa Fluor 488
goat anti-mouse IgG at 1:200 for 1 h at room
temperature. The cells were washed with PBS,
resuspended in 500 μl PBS and analyzed using FACScan
flow cytometer with CellQuest pro software (BD
Biosciences, San Jose, CA). The cells were counted as
infected if their fluorescence densities were greater than
the intensity of the uninfected cells. The amount of
infected cells relative to the untreated or siCtrl-
transfected controls was given as percent infection. At
least 10,000 cells were analyzed per sample.Statistical analysis
The results were presented as the mean ± standard devi-
ation (SD). Statistical significance was assessed by
Student’s t-test, and statistical significance was ascribed
when p<0.05.
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